Home
Drugs
Bevacizumab
Clinical Trials

Clinical Trials Related to Bevacizumab

Related studies linked through entity extraction aliases.

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

Status: COMPLETED
Phase: PHASE2

A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy

Status: COMPLETED
Phase: PHASE3

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Status: RECRUITING
Phase: PHASE2

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Status: COMPLETED
Phase: PHASE3

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Status: COMPLETED
Phase: PHASE1/PHASE2

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Status: COMPLETED
Phase: PHASE2

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Status: COMPLETED
Phase: N/A

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Status: TERMINATED
Phase: PHASE1

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Status: COMPLETED
Phase: PHASE1

GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Status: COMPLETED
Phase: PHASE2

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

Status: COMPLETED
Phase: PHASE3

Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

Status: TERMINATED
Phase: PHASE2

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Status: COMPLETED
Phase: PHASE2

Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)

Status: WITHDRAWN
Phase: PHASE2

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Status: TERMINATED
Phase: PHASE1

Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema

Status: COMPLETED
Phase: PHASE4

Bevacizumab for Neovascular Age-related Macular Degeneration

Status: COMPLETED
Phase: NA

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Status: COMPLETED
Phase: PHASE2

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Status: TERMINATED
Phase: PHASE3